🇧🇷 Capozide 25/15 in Brazil

Capozide 25/15 (CAPTOPRIL) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Capozide 25/15 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in Brazil

Frequently asked questions

Is Capozide 25/15 approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Capozide 25/15 in Brazil?

Aarxion Anda Hlding is the originator. The local marketing authorisation holder may differ — check the official source linked above.